NMC.L

NMC Health Plc
NMC Health Plc - Statement re. administration application by ADCB
8th April 2020, 14:09
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2616J
NMC Health Plc
08 April 2020
 

8 April 2020

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

NMC Health plc

 

(the "Company" or "NMC")

 

Statement regarding administration application by Abu Dhabi Commercial Bank

 

The Company refers to its announcement on 6 April 2020 concerning the application by Abu Dhabi Commercial Bank PJSC ("ADCB") for the appointment of administrators in respect of the Company at a hearing scheduled for 9 April 2020.

 

The Board has written to the Court indicating that, notwithstanding strenuous efforts to address Creditors' concerns, it has not been able to secure their alignment and support and has been advised by its counsel that it is not in a position to oppose the application successfully.  Accordingly, it expects the Company to be placed into administration in due course.

 

The individual responsible for releasing this announcement is Simon Watkins, Group Company Secretary.

 

 

Enquiries:

 

NMC Health plc

 

Asjad Yahya, Head of Investor Relations

+971 (0) 56 219 0975

 

 

FTI Consulting LLP

 

Edward Bridges / Simon Conway / Victoria Foster Mitchell

+44 (0)20 3727 1000

Shane Dolan

+971 (0)4 437 2100

 

About NMC Health

 

NMC is one of the leading private healthcare operators in the Gulf Cooperation Council ("GCC") with an international network of multi-specialty inpatient and outpatient clinics and hospitals, specialized maternity and fertility clinics, and long-term care homes hospitals across nineteen countries. NMC also ranks as one of the top two in-vitro fertilisation operators globally. The NMC Health group is recognised as a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing a selective international expansion programme since 2016, NMC has total capacity of 2,207 licensed beds across its network. Moreover, the recent formation of a joint venture with GOSI/Hassana Investment Company provides a solid platform for continued growth in the GCC region's largest healthcare market. The NMC Health group treated over 7.5 million patients in 2018. The NMC Health group is also a leading UAE supplier of products and consumables coming from healthcare related products. NMC reported revenues of US$2.1 billion for the year ended 31 December 2018.

 

In April 2012, NMC was listed on the Premium Segment of the London Stock Exchange.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRKKFBKQBKDOQK ]]>
TwitterFacebookLinkedIn